Complexes of Streptavidin-Fused Antigens with Biotinylated Antibodies Targeting Receptors on Dendritic Cell Surface: A Novel Tool for Induction of Specific T-Cell Immune Responses

被引:6
|
作者
Stanek, Ondrej [1 ,2 ]
Linhartova, Irena [1 ]
Majlessi, Laleh [3 ,4 ]
Leclerc, Claude [3 ,4 ]
Sebo, Peter [1 ]
机构
[1] ASCR Vvi, Lab Mol Biol Bacterial Pathogens, Inst Microbiol, Prague 14220, Czech Republic
[2] Inst Chem Technol, CR-16628 Prague, Czech Republic
[3] Inst Pasteur, Unite Regulat Immunitaire & Vaccinol, F-75724 Paris, France
[4] INSERM, U1041, F-75015 Paris, France
关键词
Streptavidin; Antigen delivery; Biotinylated antibody; T-cell response; Dendritic cell; Receptor targeting; MYCOBACTERIUM-TUBERCULOSIS; CORE-STREPTAVIDIN; FUSION PROTEIN; IN-VIVO; ESAT-6-CFP-10; COMPLEX; PRESENTING CELLS; DEC-205; RECEPTOR; DRUG-DELIVERY; BONE-MARROW; VACCINATION;
D O I
10.1007/s12033-011-9459-6
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The choice of tools that enable efficient targeting of exogenous antigens (Ag) for processing and presentation by professional Ag-presenting cells (APC) remains limited. This represents, indeed, a bottleneck in development of vaccines inducing specific T-cell responses. Here, we describe a novel strategy of Ag delivery into APCs. The Ag of choice is fused to the N- or C-terminus of streptavidin (SA) and tetrameric Ag-SA or SA-Ag fusion proteins are produced in E. coli and purified by 2-Iminobiotin-Agarose affinity chromatography. Alternatively, Ag-SA proteins are purified from urea extracts of E. coli inclusion bodies and refolded in vitro into functional tetramers. Complexes with biotinylated antibodies targeting cell surface receptors are formed and used to deliver the Ags of choice for processing and presentation by APCs and induction of Ag-specific CD4(+) and CD8(+) T-cell responses in vitro and in vivo.
引用
收藏
页码:221 / 232
页数:12
相关论文
共 50 条
  • [1] Complexes of Streptavidin-Fused Antigens with Biotinylated Antibodies Targeting Receptors on Dendritic Cell Surface: A Novel Tool for Induction of Specific T-Cell Immune Responses
    Ondrej Stanek
    Irena Linhartova
    Laleh Majlessi
    Claude Leclerc
    Peter Sebo
    Molecular Biotechnology, 2012, 51 : 221 - 232
  • [2] REGULATION AND TARGETING OF T-CELL IMMUNE-RESPONSES BY IGE AND IGG ANTIBODIES
    ESCURA, RB
    WASSERBAUER, E
    HAMMERSCHMID, F
    PEARCE, A
    KIDD, P
    MUDDE, GC
    IMMUNOLOGY, 1995, 86 (03) : 343 - 350
  • [3] Regulatory dendritic cells modulate immune responses via induction of T-CELL apoptotic death
    Liang, XY
    Chen, ZY
    Fung, JJ
    Qian, SG
    Lu, LN
    MICROSURGERY, 2006, 26 (01) : 21 - 24
  • [4] A Fusion Protein between Streptavidin and the Endogenous TLR4 Ligand EDA Targets Biotinylated Antigens to Dendritic Cells and Induces T Cell Responses In Vivo
    Arribillaga, Laura
    Durantez, Maika
    Lozano, Teresa
    Rudilla, Francesc
    Rehberger, Federico
    Casares, Noelia
    Villanueva, Lorea
    Martinez, Marta
    Gorraiz, Marta
    Borras-Cuesta, Francisco
    Sarobe, Pablo
    Prieto, Jesus
    Jose Lasarte, Juan
    BIOMED RESEARCH INTERNATIONAL, 2013, 2013
  • [5] Induction of specific and protective T-cell immune responses to HBsAg by the use of 1/01/0023
    Khajuria, Anamika
    Suden, Pankaj
    Sidiq, Tabasum
    Bani, Sarang
    Suri, K. A.
    Satti, N. K.
    VACCINE, 2008,
  • [6] EFFICIENT PRODUCTION OF T-CELL SPECIFIC MONOCLONAL-ANTIBODIES THROUGH INITIAL TOLERANCE INDUCTION TO NONSPECIFIC ANTIGENS
    SHARPE, RJ
    SCHWEIZER, RT
    KRISIUNAS, L
    MIHALYO, MA
    BOW, LM
    TRANSPLANTATION PROCEEDINGS, 1985, 17 (06) : 2757 - 2759
  • [7] The specific targeting of immune regulation: T-cell responses against Indoleamine 2,3-dioxygenase
    Andersen, Mads Hald
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2012, 61 (08) : 1289 - 1297
  • [8] The specific targeting of immune regulation: T-cell responses against Indoleamine 2,3-dioxygenase
    Mads Hald Andersen
    Cancer Immunology, Immunotherapy, 2012, 61 : 1289 - 1297
  • [9] DETECTION OF RECEPTORS OF SPECIFIC T-CELL SUPPRESSORS IMMUNE TO ANTIGENS H-2 AND THEIR ENRICHMENT BY FRACTIONATION ON TARGET-CELL MONOLAYER
    BRONDZ, BD
    KARAULOV, AV
    ABRONINA, IF
    MOLECULAR BIOLOGY, 1979, 13 (06) : 1001 - 1007
  • [10] Mapping the High-Risk Multiple Myeloma Cell Surface Proteome Identifies T-Cell Inhibitory Receptors for Immune Targeting
    Di Meo, Francesco
    Yu, Christina
    Cesarano, Annamaria
    Arafat, Aljoufi
    Marino, Silvia
    Roodman, G. David
    Broxmeyer, Hal E.
    Perna, Fabiana
    BLOOD, 2021, 138